---
schema_version: "secwatch.filing_event.v1"
accession: "0001110803-26-000018"
form_type: "8-K"
ticker: "ILMN"
cik: "0001110803"
company_name: "ILLUMINA, INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:17:01.556408+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Illumina Q4 revenue $1.16B (+5%), GAAP EPS $2.16; guides FY2026 rev $4.5-$4.6B

## Summary
- Revenue $1.16B in Q4 2025, up 5% YoY; ex-China revenue up 8%.
- GAAP diluted EPS $2.16; non-GAAP diluted EPS $1.35.
- FY2025 revenue $4.34B flat YoY; GAAP EPS $5.45, non-GAAP EPS $4.84.
- FY2026 guidance: revenue $4.5-$4.6B (4-6% growth); non-GAAP EPS $5.05-$5.20.
- Completed SomaLogic acquisition; China MOFCOM export ban lifted; launched Billion Cell Atlas with partners.

## SEC filing metadata
- accession: 0001110803-26-000018
- form_type: 8-K
- ticker: ILMN
- cik: 0001110803
- company_name: ILLUMINA, INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000018/0001110803-26-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000018/ilmn-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001110803-26-000018
- JSON: https://secwatch.observer/filing/0001110803-26-000018.json
- Plain text: https://secwatch.observer/filing/0001110803-26-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.